SCHEMBL341936

SCHEMBL341936

CC(=O)Nc1ccc([NH])c(S(=O)(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.60
ALDH1A1 P00352 3/20 0.51
CDK1 P06493 1/20 0.48
ATAD2 Q6PL18 1/20 0.47
CECR2 Q9BXF3 1/20 0.47
MEN1 O00255 3/20 0.45
MAPT P10636 3/20 0.45
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAOA P21397 1/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6777905 0.81 ENPP2 (0.61) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL9496107 0.80 ENPP2 (0.60) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL66550 0.80 ENPP2 (0.60) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL9358700 0.79 ENPP2 (0.58) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL9321055 0.79 ENPP2 (0.91) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL14358432 0.79 ENPP2 (0.91) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL16272370 0.78 ENPP2 (0.57) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL14502114 0.78 ALDH1A1 (0.76) ENPP2ALDH1A1CDK1MEN1MAPT
SCHEMBL6432425 0.78 ENPP2 (0.74) ENPP2ALDH1A1CDK1ATAD2CECR2
SCHEMBL14361824 0.78 ENPP2 (0.57) ENPP2ALDH1A1CDK1ATAD2CECR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10190009-B2 Ink composition, ink jet recording method using same, and colored material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2019-01-29 US disclosed
EP-2441806-B1 PORPHYRAZINE COLORING MATTER, INK COMPOSITION, RECORDING METHOD, AND COLORED OBJECT NIPPON KAYAKU KK (JP) 2017-09-06 EP disclosed
EP-2463345-B1 Ink composition, recording method using the same and recorded material SEIKO EPSON CORP (JP) 2017-01-18 EP disclosed
US-20160160065-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-06-09 US disclosed
EP-3015516-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2016-05-04 EP disclosed
EP-2420538-B1 PORPHYRAZINE DYE, INK COMPOSITION CONTAINING SAME, AND COLORED BODY NIPPON KAYAKU KK (JP) 2015-04-22 EP disclosed
US-8876273-B2 Ink composition, ink jet recording method using the same and recorded material SEIKO EPSON CORPORATION (JP) 2014-11-04 US disclosed
US-8857965-B2 Ink compostion, recording method using the same and recorded material SEIKO EPSON CORPORATION (JP) 2014-10-14 US disclosed
US-8668321-B2 Ink jet recording method and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2014-03-11 US disclosed
US-8657433-B2 Porphyrazine coloring matter, ink composition, recording method, and colored object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-02-25 US disclosed
US-7585361-B2 Porphyrazine coloring matter, ink, ink set and colored product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-09-08 US disclosed
US-7566362-B2 Ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2009-07-28 US disclosed
US-20090151599-A1 Porphyrazine Coloring Matter, Ink, Ink Set and Colored Product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-06-18 US disclosed
EP-2028239-A1 Ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2009-02-25 EP disclosed
US-20090047430-A1 INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2009-02-19 US disclosed
US-20090029120-A1 Novel Porphyrazine Coloring Matter, Ink, Ink Set and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-01-29 US disclosed
EP-2017309-A1 PORPHYRAZINE DYE, INK, INK SET, AND COLORED MATTER Nippon Kayaku Kabushiki Kaisha (JP) 2009-01-21 EP disclosed
US-20080274286-A1 INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2008-11-06 US disclosed
EP-1988135-A1 Ink, ink jet recording method, ink cartridge, recording unit, and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2008-11-05 EP disclosed
EP-1985668-A1 NOVEL PORPHYRAZINE DYE, INK, INK SET, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2008-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029120-A1 Novel Porphyrazine Coloring Matter, Ink, Ink Set and Colored Article TDO2, IDO1, JAK1 ENPP2 736/4885ALDH1A1 3741/4885CDK1 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.